BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:As the CMS introduces new guidance for RWD studies\, the FDA a
 nnounces a RWE Center to promote its use in regulatory decision-making\, 
 and RWD becomes more accessible\, investment is pouring into RWE generati
 on. It is evident RWE will play an increasingly pivotal role in the drug 
 development lifecycle\, but questions still remain for the experts optimi
 zing and applying RWE.\n\nAs the only industry meeting uniting RWE expert
 s\, the 13th IMPACCT Real-World Evidence Summit offers you the unique opp
 ortunity to consolidate\, innovate and optimize your RWE strategy at all 
 stages of the drug development lifecycle.\n\nConnect with 140+ industry p
 ioneers from Pfizer\, AstraZeneca\, Alexion\, Moderna\, and Boehringer In
 gelheim\, as they share first-hand case studies in fortifying data qualit
 y\, validating use of AI and predictive modeling in data analysis\, lever
 aging RWE to support regulatory submissions and more.\n\nDate and Time: M
 onday\, 27 October 2025 at 09:00 to Wednesday\, 29 October 2025 at 16:45\
 n
DTEND:20251029T164500
DTSTAMP:20260512T214257Z
DTSTART:20251027T090000
LOCATION:Hilton Boston Logan Airport\, One Hotel Drive\, Boston\, Massachu
 setts\, 02128\,
SEQUENCE:0
SUMMARY:As the CMS introduces new guidance for RWD studies\, the FDA annou
 nces a RWE Center to promote its use in regulatory decision-making\, and 
 RWD become...
UID:993b0e80-4a7a-480a-b374-cb0976187f98
END:VEVENT
END:VCALENDAR